Timothy E Morris
Officer at Humanigen, Inc (HGEN)
Timothy E Morris has filed 11 insider reports with the SEC since April 2021, as director at Aquestive Therapeutics, Inc. (AQST), director at DBV Technologies S.A. (DBVT) and officer at Humanigen, Inc (HGEN). Timothy E Morris made no open-market purchases or sales in the last 12 months. The latest filing, on June 12, 2026, reports grant or award at Aquestive Therapeutics, Inc. (AQST).
- Filings
- 11
- Companies
- 3
- Bought on market
- $18.2K
- Sold on market
- None
Companies where Timothy E Morris is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | $3.705 | Jun 12, 2026 | |||||
| Directorsince March 2021 | 12,000 | $18.2K | $1.52 | $9.42+520% | Aug 28, 2023 | ||
| Officer | Jul 29, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jun 10, 2026AQSTSEC Form 4 filed by Director Morris Timothy EForm 4Grant or award
- Jun 11, 2025AQSTSEC Form 4 filed by Director Morris Timothy EForm 4Grant or award
- Jun 20, 2024AQSTSEC Form 4 filed by Director Morris Timothy EForm 4Grant or award
- Aug 25, 2023+$18.2KDBVTSEC Form 4: Morris Timothy E bought $18,240 worth of Ordinary Shares (12,000 units at $1.52)Form 4Open-market purchase
- Jun 21, 2023AQSTSEC Form 4 filed by Morris Timothy EForm 4Grant or award
- Aug 16, 2022AQSTSEC Form 4 filed by Morris Timothy EForm 4Grant or award
- Jul 27, 2022HGENSEC Form 4 filed by Morris Timothy EForm 4Grant or award
- Jan 12, 2022HGENSEC Form 4 filed by Morris Timothy EForm 4Grant or award
- Dec 31, 2021HGENSEC Form 4 filed by Morris Timothy EForm 4Grant or award
- Jun 10, 2021DBVTSEC Form 4 filed by MORRIS TIMOTHY EForm 4Open-market purchase
- Mar 30, 2021DBVTSEC Form 3 filed by E Timothy MorrisForm 3New insider
Compare Timothy E Morris with
- Timothy E Morris vs Matthew W. Davis1 shared
- Timothy E Morris vs Richard J Daly1 shared
- Timothy E Morris vs Daniel Barber1 shared
- Timothy E Morris vs Sherry Korczynski1 shared
- Timothy E Morris vs Peter E. Boyd1 shared
- Timothy E Morris vs Cassie Jung1 shared
Other insiders at the same companies
- Matthew W. DavisAQST
- Richard J DalyAQST
- Daniel BarberAQST
- Sherry KorczynskiAQST
- Peter E. BoydAQST
- Cassie JungAQST
- Pharis MohideenDBVT
- Julie KropAQST
- Abigail L. JenkinsAQST
- John CochranAQST
- Gregory B BrownAQST
- Marco TagliettiAQST
- Thomas A. ZalewskiAQST
- Melina CioffiAQST
- Lori J BraenderAQST
- A Ernest Toth JrAQST
Questions about Timothy E Morris
- What is Timothy E Morris's role at Humanigen, Inc?
- Timothy E Morris reports to the SEC as officer at Humanigen, Inc (HGEN), according to the latest filing on July 29, 2022. Timothy E Morris has also filed as director at Aquestive Therapeutics, Inc. (AQST) and director at DBV Technologies S.A. (DBVT).
- How many shares does Timothy E Morris own?
- After the latest filing that states it, Timothy E Morris directly owned 12,000 shares of DBV Technologies S.A. (DBVT). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Timothy E Morris bought or sold stock recently?
- The most recent open-market purchase was on August 25, 2023: bought 12,000 shares of DBV Technologies S.A. (DBVT) for $18.2K at an average of $1.52.
- How do I get alerts when Timothy E Morris files?
- Follow Timothy E Morris on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Timothy E Morris (SEC CIK 0001191286). Totals count each trade once, skipping amendments whose original is on file, from Apr 3, 2021 on. View on SEC EDGAR · Get this as JSON